Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5120033 | 6107046 | F | 3 | 5120033-X | 20060705 | 20060918 | 20060929 | EXP | 2006090911 | PFIZER INC | 69 | YR | F | N | 20060928 | MD | GERMANY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5120033 | 1007726847 | PS | CABERGOLINE | 1 | ORAL | 1 MG (1 D), ORAL | U | D | 20664 | ||
| 5120033 | 1007745825 | C | URSO FALK | 1 | |||||||
| 5120033 | 1007745827 | C | ACETYLSALICYLIC ACID SRT | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5120033 | 1007726847 | RESTLESS LEGS SYNDROME |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5120033 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5120033 | AORTIC ARTERIOSCLEROSIS |
| 5120033 | AORTIC VALVE INCOMPETENCE |
| 5120033 | AORTIC VALVE SCLEROSIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5120033 | FGN |
| 5120033 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5120033 | 1007726847 | 19990101 | 20060706 |